Correlation between metabolic alterations and apoptosis resistance confered by BCR-ABL expression (2006)
- Authors:
- USP affiliated authors: CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; MOREIRA FILHO, CARLOS ALBERTO - ICB ; CURI, RUI - ICB ; MENDES, JOAO GUSTAVO PESSINI AMARANTE - ICB
- Unidades: FCFRP; ICB
- Subjects: METABOLISMO CELULAR; ONCOGENES
- Language: Inglês
- Imprenta:
- Publisher place: Angra dos Reis
- Date published: 2006
- Source:
- Título do periódico: Program and Abstracts Book
- Conference titles: International Cell Death Symposium on
-
ABNT
YON, M. et al. Correlation between metabolic alterations and apoptosis resistance confered by BCR-ABL expression. 2006, Anais.. Angra dos Reis: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2006. . Acesso em: 19 abr. 2024. -
APA
Yon, M., Miyasaka, K. C., Otton, R., Castro, F. A. de, Bueno-da-Silva, A. E. B., Tobo, P. R., et al. (2006). Correlation between metabolic alterations and apoptosis resistance confered by BCR-ABL expression. In Program and Abstracts Book. Angra dos Reis: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. -
NLM
Yon M, Miyasaka KC, Otton R, Castro FA de, Bueno-da-Silva AEB, Tobo PR, Vêncio R, Moreira-Filho CA, Curi R, Amarante-Mendes JGP. Correlation between metabolic alterations and apoptosis resistance confered by BCR-ABL expression. Program and Abstracts Book. 2006 ;[citado 2024 abr. 19 ] -
Vancouver
Yon M, Miyasaka KC, Otton R, Castro FA de, Bueno-da-Silva AEB, Tobo PR, Vêncio R, Moreira-Filho CA, Curi R, Amarante-Mendes JGP. Correlation between metabolic alterations and apoptosis resistance confered by BCR-ABL expression. Program and Abstracts Book. 2006 ;[citado 2024 abr. 19 ] - Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression
- Expression of pro-apoptotic bid and bik genes is decreased in chronic myeloid leukemia and low levels of bik MRNA are associated with lack of response to imatinib treatment
- Down regulation of Hematopoietic SH2 domain containing (HSH2D) in the progression of the chronic myelogenous leukemia
- Genomic approach to understand the mechanisms invilved in Bcr-Abl-mediated resistance to apoptosis
- Conversion of CD95 (Fas) type II into type I signaling by sub-lethal doses of cycloheximide
- Development and characterization of murine models of T lymphoma to investigate the impact of oncogene expression
- Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells
- T lymphoma murine models to study the impact of ectopic expression of anti-apoptotic oncogenes
- BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia
- Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
